Stock VLS VITA LIFE SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Vita Life Sciences Limited

Equities

VLS

AU000000VLS8

Pharmaceuticals

Delayed Australian S.E.
Other stock markets
 11:00:22 2024-04-16 pm EDT 		5-day change 1st Jan Change
2.43 AUD +3.85% Intraday chart for Vita Life Sciences Limited +1.25% +36.52%
Feb. 26 Vita Life Sciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023 CI

Business Summary

Vita Life Sciences Limited (Vita Life) is a pharmaceutical and healthcare company. The Company is involved in formulating, packaging, sales and distributing vitamins and supplements. Its core business is the development and distribution of over-the-counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. Its brand portfolio includes Herbs of Gold, VitaHealth, VitaScience and VitaLife. Herbs of Gold brand produces premium herbal, mineral, vitamin and superfood products. VitaHealth brand offers a comprehensive range of nutritional products that cater to every health need, from inner wellness to outer radiance. VitaScience is a vivacious nutritional supplement brand that offers practitioner strength quality formulations. Its subsidiaries include Vita Healthcare Asia Pacific Sdn Bhd, Herbs of Gold Sdn Bhd and others.

Sales per Business

AUD in Million2022Weight2023Weight Delta
Vitamins and Health Supplements
100.0 %
67 100.0 % 74 100.0 % +10.88%

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
58.6 %
37 55.8 % 43 58.6 % +16.50%
Malaysia
30.8 %
21 32.0 % 23 30.8 % +6.71%
Singapore
8.4 %
6 8.7 % 6 8.4 % +7.33%
Others
2.1 %
2 3.5 % 2 2.1 % -31.92%

Managers

Managers TitleAgeSince
Andrew OKeefe CEO
 Chief Executive Officer - 16-12-31
Chin Leng Khoo DFI
 Director of Finance/CFO - 03-12-31
June Lau COO
 Chief Operating Officer - 03-12-31
Melissa Pereira SAM
 Sales & Marketing - 17-06-30
Shaun Rutherford SAM
 Sales & Marketing - 19-12-31

Members of the board

Members of the board TitleAgeSince
Henry Townsing CHM
 Chairman 68 11-12-21
Andrew OKeefe CEO
 Chief Executive Officer - 16-12-31
Peter Osborne BRD
 Director/Board Member - 23-07-31
Jack Teoh BRD
 Director/Board Member - 22-09-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 56,400,137 12,520,371 ( 22.20 %) 0 22.20 %

Shareholders

NameEquities%Valuation
Chemical Overseas Ltd.
15.72 %
8,551,439 15.72 % 14 M $
Vicky Teoh
15.51 %
8,435,693 15.51 % 13 M $
Barings Acceptance Ltd.
13.55 %
7,371,832 13.55 % 12 M $
Anglo Australian Christian & Charitable Fund
11.54 %
6,276,040 11.54 % 10 M $
Eddie Lim Sung Tie
7.981 %
4,340,366 7.981 % 7 M $
SG Hiscock & Co. Ltd.
6.063 %
3,297,299 6.063 % 5 M $
Andrew OKeefe
2.776 %
1,510,000 2.776 % 2 M $
South Seas Holdings Pty Ltd.
2.474 %
1,345,430 2.474 % 2 M $
Henry Townsing
1.673 %
910,014 1.673 % 1 M $
Teik Wei Andrew Tan
1.492 %
811,607 1.492 % 1 M $

Company contact information

Vita Life Sciences Ltd.

102 Bath Road Unit 1

2232, Kirrawee

+

http://www.vitalifesciences.com
address Vita Life Sciences Limited(VLS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
VITA LIFE SCIENCES LIMITED Stock Vita Life Sciences Limited
+36.52% 83.6M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.79% 673B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.81% 551B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.64% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.00% 317B
ABBVIE INC. Stock AbbVie Inc.
+5.99% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.47% 210B
NOVARTIS AG Stock Novartis AG
-0.02% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-9.98% 195B
PFIZER, INC. Stock Pfizer, Inc.
-11.71% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VLS Stock
  4. Company Vita Life Sciences Limited